The analyst suggested a stoploss at Rs 142.

Buy Granules India Ltd. at a price target of Rs 122.0 and a stoploss at Rs 112 from entry point.

Commenting on the OTC segment in the US, Aurobindo Pharma MD N Govindarajan said the company expects a spurt in growth in the second half o...